Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126780141 | 12678014 | 1 | I | 20160816 | 20160823 | 20160823 | EXP | FI-PFIZER INC-2016392522 | PFIZER | GERGOV, M. POSTMORTEM BLOOD CONCENTRATIONS OF SARTANS MEASURED BY LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY. FORENSIC TOXICOLOGY. 2016;34(2):235-243 | 81.00 | YR | M | Y | 0.00000 | 20160823 | MD | FI | FI |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126780141 | 12678014 | 1 | PS | GABAPENTIN. | GABAPENTIN | 1 | UNK | 20235 | |||||||||||
126780141 | 12678014 | 2 | SS | VALSARTAN. | VALSARTAN | 1 | UNK | 0 | |||||||||||
126780141 | 12678014 | 3 | SS | PARACETAMOL | ACETAMINOPHEN | 1 | UNK | 0 | |||||||||||
126780141 | 12678014 | 4 | SS | ACEBUTOLOL | ACEBUTOLOL | 1 | UNK | 0 | |||||||||||
126780141 | 12678014 | 5 | C | IBUPROFEN. | IBUPROFEN | 1 | UNK | 0 | |||||||||||
126780141 | 12678014 | 6 | C | ETORICOXIB | ETORICOXIB | 1 | UNK | 0 |
Indications of drugs used
no results found |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126780141 | 12678014 | DE |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126780141 | 12678014 | Completed suicide | |
126780141 | 12678014 | Overdose |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |